Skip to content
OpenCapital
Get started

NextCure, Inc. NXTC Q4 2024 Annual earnings

Reported March 6, 2025 · Before market open

EPS-$4.92Miss by $0.84
EPS estimate-$4.08

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$1.98

Versus estimates

Diluted EPS

Q1 2026-$1.87Miss by $0.06Q4 2025-$0.81Beat by $1.45Q3 2025-$3.22Beat by $0.84Q2 2025-$11.29Miss by $6.67Q1 2025-$4.68Beat by $0.12
Q4 2024-$4.92Miss by $0.84

Ask the moment NextCure, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did NextCure, Inc. report Q4 2024 earnings?
NextCure, Inc. (NXTC) reported Q4 2024 earnings on March 6, 2025 before market open.
What were NextCure, Inc.'s Q4 2024 revenue and EPS?
NextCure, Inc. reported eps of $-4.92 for Q4 2024.
Did NextCure, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-4.08 by $0.84.
Where can I find NextCure, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-002402) directly on SEC EDGAR. The filing index links above go to sec.gov.